I
202
Hanneke van der Wijngaart
Chapter 1 General introduction
9
Chapter 2 The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
23
Chapter 3 Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types
55
Chapter 4 Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics
87
Chapter 5 Advancing wide implementation of precision oncology: A liquid nitrogen-free snap freezer preserves molecular profiles of biological samples
129
Chapter 6 Summarizing discussion and future perspectives
157
Chapter 7 Nederlandse samenvatting
177
Chapter 8 Appendices
187
Dankwoord
188
Curriculum vitae
195
List of publications
196
Made with FlippingBook
RkJQdWJsaXNoZXIy MTk4NDMw